Special Issue "Marine Actinomycetes: A New Source of Natural Products"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 December 2009)
Prof. Dr. Jose A. Salas
Department of Functional Biology (Area Microbiology), Faculty of Medicine, University of Oviedo, 33006 Oviedo, Spain
Phone: +34 985 103652
Fax: +34 985 103652
Interests: bioactive natural products; anticancer agents; antimicrobial agents; biosynthesis
Actinomycetes are filamentous Gram-positive bacteria with a complex life cycle which are widely distributed in terrestrial ecosystems, especially in soil. They are producers of a large number of natural products, many of them with clinical, pharmaceutical or agricultural application. In the last decades, marine actinomycetes are increasingly being isolated from marine environments demonstrating that actinomycetes are ubiquitous in marine sediments, but at lower numbers than in soils. Furthermore, marine actinomycetes have been found in symbiosis with different marine invertebrates, especially sponges. They have attracted great attention since they have developed unique metabolic and physiological capabilities that offer the potential to produce natural products with interesting pharmacological activities and therefore they provide a source of novel natural products with potential application in the near future.
Prof. Dr. Jose A. Salas
All papers should be submitted to email@example.com with copy to the Editors. To be published continuously until the deadline and papers will be listed together at the special websites. Both, research articles and review articles are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editors for announcment on this website.
Submitted papers should not have been published previously, nor be under consideration for publication elsewhere. All papers are refereed through a peer-review process. A guide for authors, sample copies and other relevant information for submitting papers are available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a paper Open Access publication fees are 1000 CHF per paper. English correction fees (250 CHF) will be added in certain cases (1250 CHF per paper for those papers that require extensive additional formatting and/or English corrections.).
- non-ribosomal peptides
- secondary metabolites
- bioactive compounds
Communication: Microarray-Based Transcriptional Profiling of Renieramycin M and Jorunnamycin C, Isolated from Thai Marine Organisms
Mar. Drugs 2009, 7(4), 483-494; doi:10.3390/md7040483
Received: 26 August 2009; in revised form: 14 October 2009 / Accepted: 19 October 2009 / Published: 19 October 2009| Download PDF Full-text (289 KB) | Download XML Full-text
Article: Isolation, Phylogenetic Analysis and Anti-infective Activity Screening of Marine Sponge-Associated Actinomycetes
Mar. Drugs 2010, 8(3), 399-412; doi:10.3390/md8030399
Received: 29 December 2009; in revised form: 3 February 2010 / Accepted: 5 February 2010 / Published: 26 February 2010| Download PDF Full-text (273 KB) | Download XML Full-text |
Last update: 10 October 2012